Advertisement
Advertisement
U.S. Markets open in 1 hr 27 mins
Advertisement
Advertisement
Advertisement
Advertisement

Mirati Therapeutics, Inc. (MRTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
118.34-2.47 (-2.04%)
At close: 04:00PM EST
118.34 0.00 (0.00%)
After hours: 04:14PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.33
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 3225.47
52 Week Low 3115.57
50-Day Moving Average 3138.30
200-Day Moving Average 3156.61

Share Statistics

Avg Vol (3 month) 3538.56k
Avg Vol (10 day) 3627.57k
Shares Outstanding 555.26M
Implied Shares Outstanding 6N/A
Float 835.55M
% Held by Insiders 11.10%
% Held by Institutions 199.46%
Shares Short (Dec 14, 2021) 43.08M
Short Ratio (Dec 14, 2021) 46.21
Short % of Float (Dec 14, 2021) 46.93%
Short % of Shares Outstanding (Dec 14, 2021) 45.58%
Shares Short (prior month Nov 14, 2021) 43.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Jul 02, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Sep 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-656.37%

Management Effectiveness

Return on Assets (ttm)-32.19%
Return on Equity (ttm)-59.11%

Income Statement

Revenue (ttm)73.5M
Revenue Per Share (ttm)1.45
Quarterly Revenue Growth (yoy)528.40%
Gross Profit (ttm)13.4M
EBITDA -481.02M
Net Income Avi to Common (ttm)-483.25M
Diluted EPS (ttm)-9.54
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.16B
Total Cash Per Share (mrq)22.32
Total Debt (mrq)45.52M
Total Debt/Equity (mrq)4.20
Current Ratio (mrq)9.60
Book Value Per Share (mrq)20.94

Cash Flow Statement

Operating Cash Flow (ttm)-327.24M
Levered Free Cash Flow (ttm)-156.82M
Advertisement
Advertisement